Genetic aspects of Alzheimer disease

被引:194
作者
Bird, Thomas D. [1 ]
机构
[1] Univ Washington, Ctr Geriatr Res Educ & Clin, VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA
关键词
Alzheimer; dementia; amyloid; neurogenetics;
D O I
10.1097/GIM.0b013e31816b64dc
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Alzheimer disease is the most common cause of dementia and represents a major public health problem. The neuropathologic findings of amyloid-beta plaques and tau containing neurofibrillary tangles represent important molecular clues to the underlying pathogenesis. Genetic factors are well recognized, but complicated. Three rare forms of autosomal-dominant early-onset familial Alzheimer disease have been identified and are associated with mutations in amyloid precursor protein, presenilin 1, and presenilin 2 genes. The more common late-onset form of Alzheimer disease is assumed to be polygenic/multifactorial. However, thus far the only clearly identified genetic risk factor for Alzheimer disease is Apo lipoprotein E. The epsilon 4 allele of Apo lipoprotein E influences age at onset of Alzheimer disease, but is neither necessary nor Sufficient for the disease. The search continues for the discovery of additional genetic influences.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 113 条
[21]   α2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease [J].
Depboylu, Candan ;
Lohmueller, Frank ;
Du, Yansheng ;
Riemenschneider, Matthias ;
Kurz, Alexander ;
Gasser, Thomas ;
Mueller, Ulrich ;
Dodel, Richard C. .
NEUROSCIENCE LETTERS, 2006, 400 (03) :187-190
[22]   α2 macroglobulin and the risk of Alzheimer's disease [J].
Dodel, RC ;
Du, Y ;
Bales, KR ;
Gao, F ;
Eastwood, B ;
Glazier, B ;
Zimmer, R ;
Cordell, B ;
Hake, A ;
Evans, R ;
Gallagher-Thompson, D ;
Thompson, LW ;
Tinklenberg, JR ;
Pfefferbaum, A ;
Sullivan, EV ;
Yesavage, J ;
Altstiel, L ;
Gasser, T ;
Farlow, MR ;
Murphy, GM ;
Paul, SM .
NEUROLOGY, 2000, 54 (02) :438-442
[23]   Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees [J].
Ertekin-Taner, N ;
Graff-Radford, N ;
Younkin, LH ;
Eckman, C ;
Baker, M ;
Adamson, J ;
Ronald, J ;
Blangero, J ;
Hutton, M ;
Younkin, SG .
SCIENCE, 2000, 290 (5500) :2303-+
[24]  
FATTER LA, 1989, ANN NEUROL, V25, P485
[25]   Economic evaluation of donepezil in moderate to severe Alzheimer disease [J].
Feldman, H ;
Gauthier, S ;
Hecker, J ;
Vellas, B ;
Hux, M ;
Xu, Y ;
Schwam, EM ;
Shah, S ;
Mastey, V .
NEUROLOGY, 2004, 63 (04) :644-650
[26]   Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease [J].
Ferrer, I ;
Rovira, MB ;
Guerra, MLS ;
Rey, MJ ;
Costa-Jussá, F .
BRAIN PATHOLOGY, 2004, 14 (01) :11-20
[27]   Role of genes and environments for explaining Alzheimer disease [J].
Gatz, M ;
Reynolds, CA ;
Fratiglioni, L ;
Johansson, B ;
Mortimer, JA ;
Berg, S ;
Fiske, A ;
Pedersen, NL .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (02) :168-174
[28]   Lack of association of the α2-macroglobulin locus on chromosome 12 in AD [J].
Gibson, AM ;
Singleton, AB ;
Smith, G ;
Woodward, R ;
McKeith, IG ;
Perry, RH ;
Ince, PG ;
Ballard, CG ;
Edwardson, JA ;
Morris, CM .
NEUROLOGY, 2000, 54 (02) :433-438
[29]   Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial [J].
Gilman, S ;
Koller, M ;
Black, RS ;
Jenkins, L ;
Griffith, SG ;
Fox, NC ;
Eisner, L ;
Kirby, L ;
Rovira, MB ;
Forette, F ;
Orgogozo, JM .
NEUROLOGY, 2005, 64 (09) :1553-1562
[30]   The natural history of Alzheimer disease - A longitudinal presymptomatic and symptomatic study of a familial cohort [J].
Godbolt, AK ;
Cipolotti, L ;
Watt, H ;
Fox, NC ;
Janssen, JC ;
Rossor, MN .
ARCHIVES OF NEUROLOGY, 2004, 61 (11) :1743-1748